Join to View Full Profile
12605 E 16th AveAurora, CO 80045
Phone+1 720-848-0000
Are you Dr. Aisner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Dara Aisner, MD is a board certified pathologist in Aurora, Colorado. She is currently licensed to practice medicine in Colorado, Pennsylvania, and Maryland. She is an Assistant Professor at University of Colorado School of Medicine.
Education & Training
University of Pennsylvania Health SystemFellowship, Molecular Genetic Pathology, 2009 - 2010
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2008
University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
CO State Medical License 2010 - 2025
MD State Medical License 2006 - 2010
PA State Medical License 2008 - 2010
American Board of Pathology Pathology - Anatomic- American Board of Pathology Clinical Informatics
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in patients with metastatic non-small cell lung cancer harboring sensitiz...Tejas Patil, Dexiang Gao, Alexander Watson, Mandy Sakamoto, Yunan Nie
Lung Cancer. 2025-01-01 - Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator's Consortium Registry Analysis.Margaret Stalker, Connor B Grady, Alex Watts, Wei-Ting Hwang, Krishna Chandrasekhara
JTO Clinical and Research Reports. 2025-01-01 - Clinical and Radiographic Benefit of a Patient With Metastatic Non-Small Cell Lung Cancer Harboring anFusion Through Use of EGFR Tyrosine Kinase Inhibitors.Amy Guimaraes-Young, Kurtis D Davies, Patricia Trevisan, Hala Nijmeh, Mary Haag
JCO Precision Oncology. 2024-12-01
Authored Content
- Updated Molecular Testing Guideline for the Selection of Lung Cancer PatientsJanuary 2018
Press Mentions
Pursuing Precision Oncology with World-Class Custom Bioinformatic PipelinesSeptember 23rd, 2024- CU Anschutz Researchers Roll Out Antibody TestJune 9th, 2020
- CU Cell Technologies Shared Resource Makes COVID-19 Proteins for Research, Antibody TestingMay 29th, 2020
- Join now to see all
